Sinphar GroupSinphar Group2015-2016 CORPORATE MEMBER
Public’s Health is Sinphar’s Ideal, this company philosophy accompanied general public for the past 30 years. After the establishment of Sinphar Pharmaceutical Co., Ltd. in 1977, Sinphar always uphold in Life, Health and Technology as company founding purposes for development and providing quality products and services for public. Sinphar Group has established CanCap Pharmaceutical Ltd. in Canada in 1997 to develop North American manufacturing and sales framework.
In year 2000, Sinphar Group has set up R&D Center, and acquired Sinphar TianLi Pharmaceutical Co., Ltd. in 2002. Together with Taiwan Sinphar Pharmaceutical Co., Ltd., these 4 divisions has developed and formed Sinphar Group. Over these years, Sinphar Group has recruited talented staffs, innovated and strengthened R&D team, purchased sophisticated testing equipments, developed most advanced cell tests and molecular biology technologies to build up premium international quality standards. Through scientific methods, explores the key of life and promotes human health as utmost commitment. Advanced to global development and strive for a better and healthier life of mankind is Sinphar’s self stringent requirement and vision.
杏輝藥品工業股份有限公司，於 1977 年由董事長李志文先生創立於宜蘭縣冬山鄉；純淨的水質、清新的空氣，是絕佳的製藥環境。杏輝藥品為通過 cGMP 、 ISO 9001 、 ISO 17025 及 ISO 14001 品質認證的專業製藥廠。 1996 年榮獲『國家磐石獎』，為製藥業第一家； 2002 年同時獲頒國家生技醫療品質獎「整體藥廠類西藥廠組」及「西藥產品自製處方組」等二項殊榮； 2003 年再度獲頒「工業永續精銳獎」。